Literature DB >> 30324831

Women with extreme low AMH values could have in vitro fertilization success.

Omar Sefrioui1, Aicha Madkour2, Smahane Aboulmaouahib1,3, Ismail Kaarouch1,2,3, Noureddine Louanjli1,3.   

Abstract

Circulating anti-müllerian hormone (AMH) and antral follicle count (AFC) are the best predictors of IVF outcomes. However, in extreme low AMH range especially for young patients, AMH prediction power loose its specificity to give real idea of pregnancy chance with IVF treatments and good prognosis of an extremely reduced ovarian reserve and expected poor response. Indeed, this retrospective study was conducted to evaluate IVF outcomes in patients following IVF-ICSI program with extremely low AMH levels (≤0.4 ng/ml; n = 390) compared to those presenting normal AMH range (1.3-2.6 ng/ml; n = 352) considered as control group. As expected, number of oocytes retrieved per patient, and embryological outcomes were significantly lower in the extremely low AMH levels group compared to control. Moreover, it was same trend concerning clinical outcomes but we have to note that even in extreme low AMH, patients could reach ineligible satisfying clinical pregnancy rate compared to control (17% vs 41%). For patients younger than 35 years, clinical pregnancy rate improved to 27%. Women with extreme low AMH values and especially younger ones, still have reasonable chances of achieving pregnancy, highlighting the default view of this category generally excluded from IVF program.

Entities:  

Keywords:  IVF success; Low anti-mti-mam.y hormone; ovarian reserve; poor responders

Mesh:

Substances:

Year:  2018        PMID: 30324831     DOI: 10.1080/09513590.2018.1505850

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / - Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care.

Authors:  Karine Morcel; Philippe Merviel; Diane Pertuisel; Pandora James; Sarah Bouée; Mathilde Le Guillou; Jean-Jacques Chabaud; Sylvie Roche; Hortense Drapier; Aurore Perrin; Damien Beauvillard
Journal:  Reprod Sci       Date:  2022-09-29       Impact factor: 2.924

2.  Protective Effects and Possible Mechanisms of Actions of Bushen Cuyun Recipe on Diminished Ovarian Reserve Induced by Cyclophosphamide in Rats.

Authors:  Mei Jiang; Weiling Wang; Jingxuan Zhang; Chunguo Wang; Yucong Bi; Pin Li; Song Yang; Jialin Li; Yan-Tong Xu; Ting Wang
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

3.  Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.

Authors:  Zhen Li; Ruolin Jia; Kexin Wang; Junwei Zhang; Bingnan Ren; Yichun Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

4.  Live birth outcomes from IVF treatments in younger patients with low AMH.

Authors:  Maho Miyagi; Keiko Mekaru; Rie Nakamura; Sugiko Oishi; Kozue Akamine; Chiaki Heshiki; Yoichi Aoki
Journal:  JBRA Assist Reprod       Date:  2021-07-21

5.  Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.

Authors:  Kai-Lun Hu; Kwanghann Gan; Yue Ying; Junyan Zheng; Ruixue Chen; Jinglei Xue; Yiqing Wu; Yifeng Liu; Yimin Zhu; Lanfeng Xing; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.